Sodium (2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]acrylate

Basic Information

View in Editor

CAS Number

130952-46-4

Molecular Formula

C13H11N2NaO2

Molecular Weight

250.23 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Dyes and Pigments Organic Dyes

Fine Chemicals Surfactants Anionic Surfactants

Basic Physical Properties

Boiling Point

468 °C at 760 mmHg

Flash Point

236.8 °C

SMILES

View in Editor

C1=CC(=CC=C1CN2C=CN=C2)C=CC(=O)[O-].[Na+]

InChI

InChI=1S/C13H12N2O2.Na/c16-13(17)6-5-11-1-3-12(4-2-11)9-15-8-7-14-10-15;/h1-8,10H,9H2,(H,16,17);/q;+1/p-1/b6-5+;

InChIKey

NCNYJCOBUTXCBR-IPZCTEOASA-M

LogP

0.69450

Complexity

289

Synonyms & References

English

130952-46-4
Ozagrel sodium
AC-15516
XanbonS
HMS3887A15
Xanbon
2-Propenoic acid, 3-(4-(1H-imidazol-1-ylmethyl)phenyl)-, sodium salt, (E)-
Cataclot
CCG-266963
OKY-046 sodium;OKY 046 sodium;OKY046 sodium
sodium 3-{4-[(1H-imidazol-1-yl)methyl]phenyl}prop-2-enoate
Ozagrel sodium [JAN]
Athrombone
DTXSID50172327
F85114
2-Propenoic acid, 3-(4-(1H-imidazol-1-ylmethyl)phenyl)-, sodium salt (1:1), (2E)-
sodium;(E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoate
BCP12393
AKOS015967214
Q27260625
Ozagrel sodium salt [MI]
Ozapen (TN)
AMY3367
AKOS015895382
2-Propenoic acid, 3-(4-(1H-imidazol-1-ylmethyl)phenyl)-, sodium salt, (2E)-
OKY-046 sodium
Sodium ozagrel
CS-3808
189224-26-8
2-Propenoic acid, 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-, sodium salt (1:1)
D01684

MDL Number

MFCD00875845

Customs Code

2933290090

FAQ

What regulatory guidelines apply to Sodium (2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]acrylate (CAS: 130952-46-4)?

Sodium (2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]acrylate (CAS: 130952-46-4) falls under the regulatory guidelines of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations, and may require FDA/EPA approval for certain applications. Manufacturers and importers are required to classify this compound according to its hazards and provide appropriate safety data sheets (SDS) and labels.

Are there alternatives to Sodium (2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]acrylate (CAS: 130952-46-4) in synthesis?

Alternatives to Sodium (2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]acrylate (CAS: 130952-46-4) in synthesis include other acrylate derivatives or imidazole-based compounds. Common reagents like acryloyl chloride or similar acrylate esters can be used as substitutes, depending on the desired properties of the final product.

What is the market or research trend for Sodium (2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]acrylate (CAS: 130952-46-4)?

The market for Sodium (2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]acrylate (CAS: 130952-46-4) is growing due to its applications in pharmaceuticals and topical treatments. Research trends are focusing on its use as a potential antimicrobial agent and in the development of novel drug delivery systems. However, the market is also being influenced by cost and availability of raw materials.

How should waste containing Sodium (2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]acrylate (CAS: 130952-46-4) be handled?

Waste containing Sodium (2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]acrylate (CAS: 130952-46-4) should be collected in appropriate containers and disposed of through professional waste disposal services. Incineration is a common method, but ensure compliance with local environmental regulations. Proper handling includes wearing protective gear and following safety protocols to prevent exposure and environmental contamination.